A PET study in 143 individuals has identified the metabolic fingerprint of long COVID in the brain, involving decreased activity in the olfactory and limbic areas, and the pons and cerebellum.
In the study of CAR-T with lymphoma, researchers are discovering that PET scans with FDG (a modified sugar molecule) predict long term response to CAR-T therapy. For patients who are not responding, this gives doctors time to switch to other treatment regimens without having to wait.
…The second generation Discovery PET/CT scanner at INITIO includes the ability to calculate the metabolic volume of a tumor, and we routinely report these emerging biomarkers to our referring physicians….
This new PET tracer compound, SMBT-1, focuses on astrocytes, which are the most abundant cell type in the brain, even more abundant than neurons. The tracer is able to selectively detect activated astrocytes, which may be a marker of undesirable brain inflammation which precedes cognitive deterioration.
Dr. Rob’s comment: Targeted radiotherapy is the process of making a drug that can lock onto a cancer cell, and then adding a radioactive atom to that drug. After we inject the material, it locks onto cancer cells, and highly targeted radioactive emissions kill the cancer cells, while sparing healthy tissue. This treatment, which has been available in Europe, Australia and the US, is now coming to clinical trials in Canada, and INITIO is excited to participate in these trials, currently in planning stages for prostate cancer, and slated to begin later this summer.
A new PET tracer, uPAR, is able to detect the functional activity of these tumours, allowing them to be more easily diagnosed and therefore referred for better treatment earlier. It can also aid physicians in determining who is at greater risk of disease progression.
Article: https://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&itemId=134558 In this study of 51 patients with melanoma on immunotherapy, the results of a PET/CT scan with the radiolabeled sugar molecule FDG, within
Article: AI gets $20M infusion to go on the offensive against Alzheimer’s Alzheimer’s Disease is, at present, an unstoppable disease which attacks memory, language, and
Article: Playing Video Games for 30 Minutes a Day Effective Against Dementia in Older Adults, Study Finds We are constantly learning what treatments are and
Nuclear medicine has entered an era when we are discovering more and more molecules which can precisely target cancer cells. In this case, the molecule
#300 – 3185 Willingdon Green
Burnaby, BC V5G 4P3
Phone: (604) 678 – 9274
Fax: (604) 678 – 9279
Toll Free: (888) 978 – 9115
INITIO is fully compliant with all DAP and CNSC accreditation requirements.
This is a Canadian website. Its content is intended only for residents of Canada.
Copyright © 2021 INITIO Medical Group Inc. All rights reserved.
Upon receiving your requisition INITIO staff will contact you via phone to gather your detailed medical history. They will fill out the appropriate intake package on your behalf. Upon your arrival at the clinic, you will be given the opportunity to review and make any necessary edits to your intake package before signing.
Alternatively, you may print the intake package at home, fill out the forms with your medical history and send it to us either through fax: (604) 678–9279 or via e-mail: info@initiomedical.ca. If you are sending us an intake package please ensure that your doctor has sent us a requisition.
As per the INITIO Medical Group Inc. cancellation policy, at the time of booking, we ask each patient to provide us with their credit card details. This information is used in the event that the patient cancels their appointment, or fails to attend their scheduled appointment.
Please note that no charges are made to the credit card on file, except in the event of an appointment cancellation or a failure to attend a scheduled appointment. All charges for the scan are made in person upon completion of the appointment, at which point the credit card authorization form will be shredded.